These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11588103)

  • 21. Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide mu-opioid receptor agonists.
    Blanchet C; Sollini M; Lüscher C
    Mol Cell Neurosci; 2003 Oct; 24(2):517-23. PubMed ID: 14572471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2.
    Tong Y; Wei J; Zhang S; Strong JA; Dlouhy SR; Hodes ME; Ghetti B; Yu L
    FEBS Lett; 1996 Jul; 390(1):63-8. PubMed ID: 8706831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.
    Beyer A; Koch T; Schröder H; Schulz S; Höllt V
    J Neurochem; 2004 May; 89(3):553-60. PubMed ID: 15086512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-protein-gated Inwardly Rectifying Potassium Channels Modulate Respiratory Depression by Opioids.
    Montandon G; Ren J; Victoria NC; Liu H; Wickman K; Greer JJ; Horner RL
    Anesthesiology; 2016 Mar; 124(3):641-50. PubMed ID: 26675532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
    Wagner EJ; Rønnekleiv OK; Kelly MJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1266-73. PubMed ID: 9618432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in GIRK1/GIRK2 deactivation kinetics and basal activity in the presence and absence of RGS4.
    Ulens C; Daenens P; Tytgat J
    Life Sci; 2000 Sep; 67(19):2305-17. PubMed ID: 11065178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter.
    Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
    Neuropharmacology; 2005 May; 48(6):853-68. PubMed ID: 15829256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
    Clark MJ; Traynor JR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional compartmentalization of opioid desensitization in primary sensory neurons.
    Samoriski GM; Gross RA
    J Pharmacol Exp Ther; 2000 Aug; 294(2):500-9. PubMed ID: 10900225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
    Knapman A; Santiago M; Connor M
    Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hesperidin induces antinociceptive effect in mice and its aglycone, hesperetin, binds to μ-opioid receptor and inhibits GIRK1/2 currents.
    Loscalzo LM; Yow TT; Wasowski C; Chebib M; Marder M
    Pharmacol Biochem Behav; 2011 Sep; 99(3):333-41. PubMed ID: 21624389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphine and oxycodone, but not fentanyl, exhibit antinociceptive effects mediated by G-protein inwardly rectifying potassium (GIRK) channels in an oxaliplatin-induced neuropathy rat model.
    Kanbara T; Nakamura A; Shibasaki M; Mori T; Suzuki T; Sakaguchi G; Kanemasa T
    Neurosci Lett; 2014 Sep; 580():119-24. PubMed ID: 25128218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
    Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
    Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice.
    Johnson EE; Chieng B; Napier I; Connor M
    Br J Pharmacol; 2006 Aug; 148(7):947-55. PubMed ID: 16783402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the endothelin receptor inhibits the G protein-coupled inwardly rectifying potassium channel by a phospholipase A2-mediated mechanism.
    Rogalski SL; Cyr C; Chavkin C
    J Neurochem; 1999 Apr; 72(4):1409-16. PubMed ID: 10098843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid receptors from a lower vertebrate (Catostomus commersoni): sequence, pharmacology, coupling to a G-protein-gated inward-rectifying potassium channel (GIRK1), and evolution.
    Darlison MG; Greten FR; Harvey RJ; Kreienkamp HJ; Stühmer T; Zwiers H; Lederis K; Richter D
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8214-9. PubMed ID: 9223341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.